Beta Bionics, Inc. — Director's Dealing 2025

Jan 30, 2025

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Beta Bionics, Inc. (BBNX)
CIK: 0001674632
Period of Report: 2025-01-29

Reporting Person: Saint Sean (N/A)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (right to buy)	$7.51	2032-07-31	Class B Common Stock (749445)		Direct
Employee Stock Option (right to buy)	$7.51	2032-07-31	Class B Common Stock (83268)		Direct
Employee Stock Option (right to buy)	$5.10	2033-09-13	Class B Common Stock (494198)		Direct
Employee Stock Option (right to buy)	$5.10	2033-09-13	Class B Common Stock (54911)		Direct

Footnotes

F1: One-fourth of the shares subject to this option shall vest one year after August 1, 2022, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof.

F2: In accordance with the Issuer's Amended and Restated Certificate of Incorporation, the Issuer's outstanding shares of Class B Common Stock will convert into an equal number of shares of Common Stock immediately prior to the closing of the initial public offering.

F3: The shares subject to this option shall vest in 12 equal monthly installments measured four years after August 1, 2022.

F4: One-fourth of the shares subject to this option shall vest one year after August 15, 2022, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof.

F5: The shares subject to this option shall vest in 12 equal monthly installments following the four-year anniversary of August 15, 2022.